Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.9400
+0.0309 (3.40%)
Sep 22, 2026, 9:17 AM EDT - Market open
Sunshine Biopharma Employees
Sunshine Biopharma had 50 employees as of December 31, 2025. The number of employees decreased by 2 or -3.85% compared to the previous year.
Employees
50
Change (1Y)
-2
Growth (1Y)
-3.85%
Revenue / Employee
$706,935
Profits / Employee
-$116,653
Market Cap
3.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 50 | -2 | -3.85% | 50 | 0 |
| Dec 31, 2024 | 52 | 8 | 18.18% | 52 | 0 |
| Dec 31, 2023 | 44 | -2 | -4.35% | 44 | 0 |
| Dec 31, 2022 | 46 | 43 | 1,433.33% | 46 | 0 |
| Dec 31, 2021 | 3 | 0 | - | 3 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| China SXT Pharmaceuticals | 56 |
| IM Cannabis | 44 |
| cbdMD | 42 |
| RedHill Biopharma | 13 |
| Sonoma Pharmaceuticals | 10 |
| Gelteq | 8 |
| PRF Technologies | 7 |
| InMed Pharmaceuticals | 6 |
SBFM News
- 6 days ago - Sunshine Biopharma advances lead Coronavirus drug candidate - TheFly
- 6 days ago - Sunshine Biopharma Advances Lead Coronavirus Drug Candidate into IND-Enabling Studies - Accesswire
- 22 days ago - Sunshine Biopharma announces Health Canada approval for atenolol - TheFly
- 22 days ago - Health Canada Approves Sunshine Biopharma's Atenolol for Treating and Managing Cardiovascular Conditions - Accesswire
- 24 days ago - Sunshine Biopharma files to sell 24.48M shares of common stock - TheFly
- 27 days ago - Sunshine Biopharma provides update, outlines plans for oncology project - TheFly
- 27 days ago - Sunshine Biopharma Reports In Vivo Tumor Suppression with K1.1 mRNA and Advances Novel mRNA-Cancer Vaccine Strategy for Lung Cancer - Accesswire
- 4 weeks ago - Sunshine Biopharma receives Canadian regulatory approval for Enalapril - TheFly